ArticleScientific reports2024

The role of graft T-cell size in patients receiving alemtuzumab serotherapy for non-malignant disorders: results of an institutional protocol.

Ambreen Pandrowala et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.